Óscar Fabregat-Andrés
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Óscar Fabregat-Andrés has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Ridocci-Soriano
Servicio de Cardiología, Consorcio Hospital General Universitario de Valencia, Valencia, España; Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España
5 shared publications Miguel Corbí-Pascual
Departamento de Cardiología, Complejo Hospitalario de Albacete, Albacete, Spain
4 shared publicationsSalvador Morell
4 shared publications- Blanca Trejo-Velasco
Department of Cardiology, University Hospital of Salamanca, 37007 Salamanca, Spain
3 shared publications Francisco Ridocci-Soriano
Cardiovascular Institute, General University Hospital from Valencia-Spain
3 shared publicationsL. Fácila
Servicio de Cardiología, Consorcio Hospital General Universitario de Valencia, Valencia, España
3 shared publications
Latest Publications
- Open Access
- 19 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 491
Mean Velocity of the Pulmonary Artery as a Clinically Relevant Prognostic Indicator in Patients with Heart Failure with Preserved Ejection Fraction
Background: Right ventricular (RV) to pulmonary circulation (PC) coupling can stratify prognosis in heart failure (HF). In this study, we assessed the prognostic role of the mean velocity of the pulmonary artery (mvPA) determined by cardiac magnetic resonance (CMR) in HF with preserved ejection fraction (HFpEF). Methods: Inclusion of 58 HFpEF outpatients that underwent CMR with measurement of RV–PC coupling parameters including mvPA between 2016 and 2019. The primary combined endpoint was a composite of HF readmissions and all-cause mortality. Results: Optimal cut-off value of mvPA calculated by receiver operating curve for the prediction of the primary endpoint was 9 cm/s. Over a median follow-up of 23 months (interquartile range: 24), 21 patients met the primary endpoint. The primary endpoint was more frequent in patients with mvPA ≤ 9 cm/s, as indicated by Kaplan–Meier survival curves; Log-Rank: 9.193, p = 0.02, regardless of RV dysfunction. On Cox multivariate analysis, mvPA ≤ 9 cm/s emerged as an independent prognostic predictor of the primary endpoint (HR: 4.11, 95% CI: 1.28–13.19, p = 0.017), together with left atrial area by CMR (HR: 1.08, 95% CI: 1.01–1.24, p = 0.034). Conclusions: In our HFpEF cohort, mvPA was associated with a higher rate of the primary endpoint, regardless of RV function, thus enabling identification of patients at higher risk of cardiovascular events before structural damage onset.
- 19 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 491
Open AccessMean Velocity of the Pulmonary Artery as a Clinically Relevant Prognostic Indicator in Patients with Heart Failure with Preserved Ejection Fraction
Background: Right ventricular (RV) to pulmonary circulation (PC) coupling can stratify prognosis in heart failure (HF). In this study, we assessed the prognostic role of the mean velocity of the pulmonary artery (mvPA) determined by cardiac magnetic resonance (CMR) in HF with preserved ejection fraction (HFpEF). Methods: Inclusion of 58 HFpEF outpatients that underwent CMR with measurement of RV–PC coupling parameters including mvPA between 2016 and 2019. The primary combined endpoint was a composite of HF readmissions and all-cause mortality. Results: Optimal cut-off value of mvPA calculated by receiver operating curve for the prediction of the primary endpoint was 9 cm/s. Over a median follow-up of 23 months (interquartile range: 24), 21 patients met the primary endpoint. The primary endpoint was more frequent in patients with mvPA ≤ 9 cm/s, as indicated by Kaplan–Meier survival curves; Log-Rank: 9.193, p = 0.02, regardless of RV dysfunction. On Cox multivariate analysis, mvPA ≤ 9 cm/s emerged as an independent prognostic predictor of the primary endpoint (HR: 4.11, 95% CI: 1.28–13.19, p = 0.017), together with left atrial area by CMR (HR: 1.08, 95% CI: 1.01–1.24, p = 0.034). Conclusions: In our HFpEF cohort, mvPA was associated with a higher rate of the primary endpoint, regardless of RV function, thus enabling identification of patients at higher risk of cardiovascular events before structural damage onset.
- 1 February 2017
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 18 (2) , 69-73
Metformin and risk of long-term mortality following an admission for acute heart failure
Failure. We sought to evaluate the association between metformin therapy and risk of long-term mortality in patients discharged for decompensated heart failure. Methods We included 835 consecutive type 2 diabetic patients discharged from a cardiology department of a third-level center. All-cause mortality was considered as the primary endpoint and the effect of metformin therapy across the most representative subgroups in heart failure as a secondary endpoint. The association between metformin with all-cause mortality was evaluated by using a Cox regression method. Multivariate analysis included solid prognostic covariates in heart failure. Results At a mean follow-up of 2.4 ± 2 years, mortality rates were significantly lower in patients on treatment with metformin: 1.34 (1.04–1.65) × 10 vs. 2.24 (2.0–2.51) × 10 person-years (P < 0.001). Kaplan–Meier curve revealed a progressive separation of curves already observed during first months of follow-up (log-rank test P < 0.001). In multivariate analysis, this prognostic association remained significant. Conclusion In this cohort of patients with acute heart failure and diabetes, metformin appears to be well tolerated and may be associated with favorable clinical outcomes....
- 1 February 2017
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 18 (2) , 69-73
Metformin and risk of long-term mortality following an admission for acute heart failure
Failure. We sought to evaluate the association between metformin therapy and risk of long-term mortality in patients discharged for decompensated heart failure. Methods We included 835 consecutive type 2 diabetic patients discharged from a cardiology department of a third-level center. All-cause mortality was considered as the primary endpoint and the effect of metformin therapy across the most representative subgroups in heart failure as a secondary endpoint. The association between metformin with all-cause mortality was evaluated by using a Cox regression method. Multivariate analysis included solid prognostic covariates in heart failure. Results At a mean follow-up of 2.4 ± 2 years, mortality rates were significantly lower in patients on treatment with metformin: 1.34 (1.04–1.65) × 10 vs. 2.24 (2.0–2.51) × 10 person-years (P < 0.001). Kaplan–Meier curve revealed a progressive separation of curves already observed during first months of follow-up (log-rank test P < 0.001). In multivariate analysis, this prognostic association remained significant. Conclusion In this cohort of patients with acute heart failure and diabetes, metformin appears to be well tolerated and may be associated with favorable clinical outcomes....
- 1 April 2016
- Published by Elsevier in Revista Clínica Española
- Vol. 216 (3) , 121-125
Valor pronóstico del análisis del vector de bioimpedancia en pacientes ingresados por descompensación aguda de insuficiencia cardiaca: cohorte de validación
- 1 April 2016
- Published by Elsevier in Revista Clínica Española
- Vol. 216 (3) , 121-125
Valor pronóstico del análisis del vector de bioimpedancia en pacientes ingresados por descompensación aguda de insuficiencia cardiaca: cohorte de validación
- Open Access
- 1 March 2016
- Published by Instituto Mexicano del Seguro Social in Revista Colombiana de Cardiología
- Vol. 23 (2) , 155-156
Triple terapia antitrombótica en práctica real: utilidad pronóstica de la escala HAS-BLED
- 1 March 2016
- Published by Instituto Mexicano del Seguro Social in Revista Colombiana de Cardiología
- Vol. 23 (2) , 155-156
Open AccessTriple terapia antitrombótica en práctica real: utilidad pronóstica de la escala HAS-BLED
- 9 February 2016
- Published by Elsevier in Revista Clínica Española (English Edition)
- Vol. 216 (3) , 121-125
Prognostic value of analysing the bioimpedance vector for patients hospitalized for acute decompensated heart failure: A validation cohort
- 9 February 2016
- Published by Elsevier in Revista Clínica Española (English Edition)
- Vol. 216 (3) , 121-125
Prognostic value of analysing the bioimpedance vector for patients hospitalized for acute decompensated heart failure: A validation cohort
- Open Access
- 26 November 2015
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 16 (8) , 622-629
mRNA PGC-1α levels in blood samples reliably correlates with its myocardial expression: study in patients undergoing cardiac surgery
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology
- 26 November 2015
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 16 (8) , 622-629
Open AccessmRNA PGC-1α levels in blood samples reliably correlates with its myocardial expression: study in patients undergoing cardiac surgery
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology
- 10 November 2015
- Vol. 56 (10) , 1258-1259
New score based on early repolarization in precordial leads for detection of left ventricular hypertrophy in young soccer players.
- 10 November 2015
- Vol. 56 (10) , 1258-1259
New score based on early repolarization in precordial leads for detection of left ventricular hypertrophy in young soccer players.
- 1 August 2015
- Published by Elsevier in Revista Clínica Española
- Vol. 215 (6) , 315-319
Prescripción de anticoagulación oral en pacientes con fibrilación auricular e ingreso previo en un servicio de cardiología. Experiencia en un hospital terciario
- 1 August 2015
- Published by Elsevier in Revista Clínica Española
- Vol. 215 (6) , 315-319
Prescripción de anticoagulación oral en pacientes con fibrilación auricular e ingreso previo en un servicio de cardiología. Experiencia en un hospital terciario